Ear Nerve Stimulation for Chronic Back Pain: Does It Work?
30 Oct 2026
A new randomised trial of 70 adults with chronic low back pain found that four weeks of ear-based nerve stimulation (taVNS) was followed by lower pain scores [1]. But both groups in the trial improved by a similar amount, and there was no placebo arm, so the study can't tell us how much of the relief came from the stimulation itself. Treat it as an encouraging early signal, not proof.
Ear Nerve Stimulation for Chronic Back Pain at a glance
- What was tested: a small electrode on the outer ear, used for four weeks, compared with stimulation of a different ear nerve [1].
- Result: pain, bothersomeness and interference all fell in both groups, with no difference between them [1].
- Main limit: no sham (placebo) group, and only 51 of 70 people finished [1].
- Wider evidence: sham-controlled trials in other pain conditions are mixed [2,3].
- Safety: no serious adverse events were reported in a 12-week knee osteoarthritis trial [3].
What is ear nerve stimulation (taVNS)?
Transcutaneous auricular vagus nerve stimulation, or taVNS, sends a very mild electrical current through a small clip or electrode on the outer ear. The skin there is supplied by a branch of the vagus nerve, which connects to brain areas involved in pain, mood and sleep. Nothing is inserted and there is no surgery.
At Brain Bridge Clinic, taVNS is one of several neuromodulation options. It is used as part of a wider pain plan, not as a stand-alone fix.
What did the new back pain trial find?
Researchers at Massachusetts General Hospital randomised 70 adults with chronic low back pain to four weeks of either taVNS or stimulation of the greater auricular nerve, a different nerve in the ear [1]. Fifty-one people completed the study, 25 in one group and 26 in the other.
Pain intensity, how bothersome the pain felt, and how much it got in the way of daily life all dropped in both groups. The difference between the groups was not statistically significant [1]. Brain scans before and after also showed changes in how the thalamus, a relay station for pain signals, connects with other brain regions [1].
Does this prove taVNS works for back pain?
No, and the authors don't claim it does. Because both groups received a real ear stimulation and there was no inactive sham group, the trial can't separate the effect of the treatment from the effect of expecting to improve, natural ups and downs, or simply attending a clinic regularly [1]. The brain-scan changes are interesting for understanding how it might act. They don't show that patients feel better because of those changes.
One author disclosed a patent related to ear vagus nerve stimulation [1]. That doesn't invalidate the results, but independent replication would help.
What does other research on taVNS and pain say?
The picture outside back pain is mixed. In a trial of 70 people having lung surgery, active taVNS did not reduce opioid use compared with sham. Resting pain scores and the rate of rebound pain were lower, though the authors call the clinical meaning uncertain [2]. In 68 people with chronic knee osteoarthritis, twelve weeks of vagus nerve stimulation improved pain and function more than sham, with benefits lasting four weeks after stopping and no serious adverse events [3]. A smaller sham-controlled trial in migraine found fewer migraine days with real stimulation over four weeks [4].
Taken together, these are small trials with short follow-up, spread across different conditions. They justify further study. They don't yet justify promising any one person relief.
- Back pain: encouraging change in pain scores, but no placebo comparison [1].
- Post-surgical pain: less pain at rest, no reduction in opioid use [2].
- Knee osteoarthritis: better pain and function than sham over 12 weeks [3].
- Migraine: fewer migraine days than sham over four weeks [4].
| Condition | Comparison | Main finding |
|---|---|---|
| Chronic low back pain | taVNS vs another ear nerve | Both groups improved, no difference [1] |
| Pain after lung surgery | taVNS vs sham | Lower pain scores, same opioid use [2] |
| Knee osteoarthritis | taVNS vs sham | Better pain and function [3] |
| Migraine | taVNS vs sham | Fewer migraine days [4] |
What recent taVNS trials have shown, by condition [1-4].
Who might consider taVNS for chronic back pain?
It isn't a first step. Back pain that is new, severe, follows an injury, or comes with leg weakness, numbness, fever, or loss of bladder or bowel control needs medical assessment first. Those are not signs to wait on.
For long-standing pain that has not responded well to exercise-based physiotherapy, medicines or other measures, a clinician may discuss neuromodulation as an add-on. People with a pacemaker or other implanted electronic device, or who are pregnant, need a specific safety check before any electrical stimulation. The decision should rest on your history, examination and goals, not on one trial.
Getting help in Delhi
At Brain Bridge Clinic in Safdarjung Enclave, New Delhi, a chronic pain assessment starts with a detailed history: when the pain began, what makes it better or worse, what you have already tried, and how it affects work, sleep and mood. Your clinician examines you, reviews any scans or reports you bring, and screens for warning signs that need urgent investigation. If neuromodulation such as taVNS looks suitable, we explain what is known and not known about it, how a course would be paced, and how progress would be measured, so the decision stays yours. If you'd like to talk it through, you can book an assessment with the clinic team.
Related pages: Chronic Pain, taVNS, Neuromodulation.
Frequently asked questions
Is taVNS the same as vagus nerve stimulation surgery?
No. Implanted vagus nerve stimulation is a surgical procedure. taVNS uses a small surface electrode on the outer ear and nothing is implanted.
Does taVNS hurt?
It usually feels like a mild tingling or buzzing. The current is set to a comfortable level, and you can ask for it to be turned down.
How long would a course of taVNS take?
The back pain trial used four weeks of treatment [1], and the knee osteoarthritis trial ran twelve weeks [3]. The right length for you would be decided after assessment.
Can taVNS replace my pain medicines or physiotherapy?
There's no evidence that it should. Where it is used, it is generally considered as an add-on. Don't stop prescribed medicines without speaking to your doctor.
Is taVNS safe?
No serious adverse events were reported in the knee osteoarthritis trial [3], but the trials are small. Skin irritation at the electrode site is the usual concern. Your clinician will screen for conditions that make it unsuitable.
Where can I get urgent help if pain is affecting my mental health?
If you feel hopeless or unsafe, call Tele-MANAS on 14416 (free, 24/7), or 112 in an emergency.
References
- Wu Y, Kong Q, Sacca V, et al. Effects of transcutaneous auricular nerve stimulation on thalamic relay: A randomized brain imaging study in chronic low back pain patients. Brain research. 2026;1889:150447. doi:10.1016/j.brainres.2026.150447. PMID 42361949.
- Zhang J, Chen Q, Shen Q, et al. Effectiveness of Transcutaneous Auricular Vagal Nerve Stimulation on Alleviating Postoperative Pain Following Thoracoscopic Lobectomy: A Participant- and Assessor-blinded, Randomized Controlled Trial. The Clinical journal of pain. 2025;41(10). doi:10.1097/AJP.0000000000001315. PMID 40775700.
- Elsehrawy GG, Ibrahim ME, A Moneim NH, et al. Transcutaneous vagus nerve stimulation as a pain modulator in knee osteoarthritis: a randomized controlled clinical trial. BMC musculoskeletal disorders. 2025;26(1):68. doi:10.1186/s12891-025-08288-6. PMID 39828740.
- Zhang Y, Huang Y, Li H, et al. Transcutaneous auricular vagus nerve stimulation (taVNS) for migraine: an fMRI study. Regional anesthesia and pain medicine. 2021;46(2):145-150. doi:10.1136/rapm-2020-102088. PMID 33262253.